Livforsakringsbolaget Skandia Omsesidigt Buys Shares of 2,468 Intuitive Surgical, Inc. $ISRG

Livforsakringsbolaget Skandia Omsesidigt bought a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 2,468 shares of the medical equipment provider’s stock, valued at approximately $981,000.

Several other hedge funds have also recently modified their holdings of the business. Prosperity Consulting Group LLC raised its stake in Intuitive Surgical by 0.5% during the 3rd quarter. Prosperity Consulting Group LLC now owns 4,033 shares of the medical equipment provider’s stock valued at $1,804,000 after buying an additional 19 shares during the last quarter. Cornerstone Planning Group LLC boosted its stake in shares of Intuitive Surgical by 11.5% in the 4th quarter. Cornerstone Planning Group LLC now owns 203 shares of the medical equipment provider’s stock worth $106,000 after buying an additional 21 shares during the last quarter. North Star Investment Management Corp. grew its holdings in shares of Intuitive Surgical by 8.5% in the fourth quarter. North Star Investment Management Corp. now owns 269 shares of the medical equipment provider’s stock worth $152,000 after acquiring an additional 21 shares during the period. Valeo Financial Advisors LLC increased its position in Intuitive Surgical by 0.4% during the fourth quarter. Valeo Financial Advisors LLC now owns 4,941 shares of the medical equipment provider’s stock valued at $2,798,000 after acquiring an additional 21 shares during the last quarter. Finally, Dana Investment Advisors Inc. increased its position in Intuitive Surgical by 1.9% during the fourth quarter. Dana Investment Advisors Inc. now owns 1,140 shares of the medical equipment provider’s stock valued at $646,000 after acquiring an additional 21 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Up 1.5%

NASDAQ ISRG opened at $372.60 on Friday. Intuitive Surgical, Inc. has a 12 month low of $328.57 and a 12 month high of $603.88. The stock has a market cap of $131.63 billion, a price-to-earnings ratio of 42.68, a PEG ratio of 2.69 and a beta of 1.46. The company’s 50 day moving average is $384.60 and its two-hundred day moving average is $432.76.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share for the quarter, topping analysts’ consensus estimates of $2.48 by $0.32. The business had revenue of $2.89 billion during the quarter, compared to analyst estimates of $2.83 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The company’s revenue was up 18.4% on a year-over-year basis. During the same period in the prior year, the business posted $1.81 earnings per share. Sell-side analysts forecast that Intuitive Surgical, Inc. will post 8.87 EPS for the current year.

Insider Buying and Selling

In related news, EVP Mark Brosius sold 77 shares of the company’s stock in a transaction on Friday, August 21st. The shares were sold at an average price of $375.57, for a total value of $28,918.89. Following the completion of the transaction, the executive vice president owned 881 shares of the company’s stock, valued at approximately $330,877.17. This represents a 8.04% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Iman Jeddi sold 5,625 shares of the stock in a transaction on Monday, June 1st. The stock was sold at an average price of $420.55, for a total value of $2,365,593.75. Following the completion of the sale, the senior vice president owned 6,463 shares of the company’s stock, valued at $2,718,014.65. The trade was a 46.53% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 17,283 shares of company stock worth $7,015,429 in the last three months. Corporate insiders own 0.60% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on ISRG shares. BMO Capital Markets restated an “outperform” rating on shares of Intuitive Surgical in a research note on Monday, July 20th. KeyCorp reiterated an “overweight” rating on shares of Intuitive Surgical in a research note on Wednesday, August 12th. JPMorgan Chase & Co. dropped their price objective on shares of Intuitive Surgical from $550.00 to $450.00 and set an “overweight” rating on the stock in a report on Friday, July 17th. Weiss Ratings restated a “hold (c)” rating on shares of Intuitive Surgical in a research report on Friday, August 14th. Finally, Leerink Partners reduced their target price on shares of Intuitive Surgical from $573.00 to $454.00 and set an “outperform” rating for the company in a report on Friday, July 17th. Twenty-two analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus target price of $508.68.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.